INBS (Intelligent Bio Solutions) EPS without NRI: $-11.57 (TTM As of Mar. 2026)


INBS Intelligent Bio Solutions Inc INBS
48 GF Score
Price $2.15
GF Value $2.60
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Intelligent Bio Solutions EPS without NRI?

Intelligent Bio Solutions INBS -1.60% 48 EPS without NRI is $-11.57 as of Mar. 2026. GuruFocus rates INBS with a GF Score™ of 48/100 and a GF Value™ of $2.60 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 662 Medical Devices & Instruments companies, Intelligent Bio Solutions ranks better than 95.77% on this metric.

Intelligent Bio Solutions's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $-1.82. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-11.57.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 75.70% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 55.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Intelligent Bio Solutions's EPS without NRI or its related term are showing as below:

INBS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -13.7   Med: 4.5   Max: 75.7
Current: 75.7

During the past 9 years, Intelligent Bio Solutions's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 75.70% per year. The lowest was -13.70% per year. And the median was 4.50% per year.

INBS's 3-Year EPS without NRI Growth Rate is ranked better than
95.77% of 662 companies
in the Medical Devices & Instruments industry
Industry Median: 8.15 vs INBS: 75.70

Intelligent Bio Solutions's EPS (Diluted) for the three months ended in Mar. 2026 was $-1.80. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-12.20.

Intelligent Bio Solutions's EPS (Basic) for the three months ended in Mar. 2026 was $-1.80. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-12.20.


Intelligent Bio Solutions  (NAS:INBS) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Intelligent Bio Solutions EPS without NRI Related Terms


Intelligent Bio Solutions EPS without NRI Historical Data

* Premium members only.

The historical data trend for Intelligent Bio Solutions's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intelligent Bio Solutions EPS without NRI Chart

Intelligent Bio Solutions Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only -1,569.49 -1,358.95 -1,029.39 -64.90 -19.58

Intelligent Bio Solutions Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.41 -3.77 -3.19 -2.79 -1.82

INBS vs ITOC, WOK, BMRA: EPS without NRI Comparison

For the Medical Devices subindustry, Intelligent Bio Solutions's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelligent Bio Solutions PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Intelligent Bio Solutions's PE Ratio without NRI falls into.


INBS
48GF Score
Intelligent Bio Solutions Inc INBS
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intelligent Bio Solutions EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-11.57 mean?
Intelligent Bio Solutions (INBS) has a EPS without NRI of $-11.57 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Intelligent Bio Solutions and its competitors. According to the industry distribution chart, Intelligent Bio Solutions ranks #28 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 4.2%.
Is Intelligent Bio Solutions' EPS without NRI too high?
Intelligent Bio Solutions' current EPS without NRI is $-11.57. Based on the distribution chart, Intelligent Bio Solutions ranks #28 out of 662 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Intelligent Bio Solutions has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' EPS without NRI compare to ITOC and WOK?
According to the Medical Devices & Instruments industry distribution chart, Intelligent Bio Solutions ranks #28 out of 662 companies for EPS without NRI. This places Intelligent Bio Solutions in the top 4% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Intelligent Bio Solutions and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intelligent Bio Solutions's current EPS without NRI is $-11.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.60, compared to a current price of $2.15 — trading 17.3% below its estimated fair value. The current EPS without NRI is $-11.57. Intelligent Bio Solutions' overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current EPS without NRI is $-11.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intelligent Bio Solutions (INBS) Overvalued in 2026?

Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued. The current stock price of $2.15 is trading 17.3% below its estimated GF Value™ of $2.60. GuruFocus considers Intelligent Bio Solutions to be Modestly Undervalued.

Key valuation signals for INBS:

  • EPS without NRI: $-11.57
  • GF Value™: $2.60 vs. price of $2.15 (17.3% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Intelligent Bio Solutions Business Description

Address 135 West, 41ST Street, 5th Floor, New York, NY, USA, 10036
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
48GF Score

Get the complete analysis for INBS

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.15
Price
$2.60
GF Value